Loading…

Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice

Oxaliplatin, a platinum-based chemotherapy drug, frequently causes acute and chronic peripheral neuropathies including mechanical hyperalgesia. These adverse effects hinder anticancer therapy with the drug. In this study, we examined several drugs that might prevent oxaliplatin-induced peripheral ne...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Pharmacological Sciences 2014/07/20, Vol.125(3), pp.292-299
Main Authors: Ohsawa, Masahiro, Otake, Saki, Murakami, Tomoyasu, Yamamoto, Shohei, Makino, Toshiaki, Ono, Hideki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963
cites cdi_FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963
container_end_page 299
container_issue 3
container_start_page 292
container_title Journal of Pharmacological Sciences
container_volume 125
creator Ohsawa, Masahiro
Otake, Saki
Murakami, Tomoyasu
Yamamoto, Shohei
Makino, Toshiaki
Ono, Hideki
description Oxaliplatin, a platinum-based chemotherapy drug, frequently causes acute and chronic peripheral neuropathies including mechanical hyperalgesia. These adverse effects hinder anticancer therapy with the drug. In this study, we examined several drugs that might prevent oxaliplatin-induced peripheral neuropathy. Single intraperitoneal (i.p.) injection of oxaliplatin (10 mg/kg) induced cold allodynia (acetone test) and mechanical hyperalgesia (von Frey test). Gabapentin, but not simvastatin and atorvastatin, prevented oxaliplatin-induced mechanical hyperalgesia without affecting cold allodynia. Moreover, oxaliplatin caused phosphorylation of cofilin protein in the spinal cord, which has been shown to be involved in the neuropathic hyperalgesia. This increased phosphorylation of cofilin was also attenuated by gabapentin treatment. These results suggest that gabapentin is useful for relieving oxaliplatin-induced mechanical hyperalgesia and that the pathogenic mechanisms of cold allodynia and mechanical hyperalgesia differ.
doi_str_mv 10.1254/jphs.14058FP
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_abc7682753dc40b291600e86a2ad490f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1347861319301239</els_id><doaj_id>oai_doaj_org_article_abc7682753dc40b291600e86a2ad490f</doaj_id><sourcerecordid>1547830321</sourcerecordid><originalsourceid>FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963</originalsourceid><addsrcrecordid>eNqFUk1v1DAQjRCIlsKNM8qRA1vGH7GdIyp0u1Kr9gBna-JMtl5lk2BnK_rvcTbbnJC4jK2Z5zcz7znLPjK4ZLyQX3fDY7xkEgpz_fAqO2dC6pVR0rxe7kycZe9i3AFwA0y9zc64LEtgrDjP1muscKBu9F3-EOgp3WJ-_wdbP7SYkqtNVx8c1fkduUfsvMM2v3keKGC7pegxT-_uvKP32ZsG20gfTudF9uv6x8-rm9Xt_Xpz9e125bSW46risii0Jq4dGoBKGdSShCQOZcNko1UtXMWJqqrijUZkjQSjGlUjCiyVuMg2M2_d484Owe8xPNsevT0m-rC1GEbvWrJYOa0M14WonYSKl0wBkFHIsZYlNInr88w1hP73geJo9z46alvsqD9Ey5SZCBQv_g8tpDYCBGcJ-mWGutDHGKhZpmRgJ8fs5Jg9OZbgn07Mh2pP9QJ-sSgB1jMgVSf5-671HdldfwhdUtq6RkXnqbMcmLSQOoCwANoCL_kUSp5Wh2LS7vvMtIsjbmlp9SLYPBcvrDjG04RLOfkfLHWJRs00lHx-8hTssX_6JD6QG5MR_t-r_gUQ_dIA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547830321</pqid></control><display><type>article</type><title>Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice</title><source>ScienceDirect Journals</source><creator>Ohsawa, Masahiro ; Otake, Saki ; Murakami, Tomoyasu ; Yamamoto, Shohei ; Makino, Toshiaki ; Ono, Hideki</creator><creatorcontrib>Ohsawa, Masahiro ; Otake, Saki ; Murakami, Tomoyasu ; Yamamoto, Shohei ; Makino, Toshiaki ; Ono, Hideki ; Musashino University ; Department of Pharmacognosy ; Graduate School of Pharmaceutical Sciences ; Nagoya City University ; Laboratory of Clinical Pharmacy and Pharmacology ; Faculty of Pharmacy ; Laboratory of CNS Pharmacology</creatorcontrib><description>Oxaliplatin, a platinum-based chemotherapy drug, frequently causes acute and chronic peripheral neuropathies including mechanical hyperalgesia. These adverse effects hinder anticancer therapy with the drug. In this study, we examined several drugs that might prevent oxaliplatin-induced peripheral neuropathy. Single intraperitoneal (i.p.) injection of oxaliplatin (10 mg/kg) induced cold allodynia (acetone test) and mechanical hyperalgesia (von Frey test). Gabapentin, but not simvastatin and atorvastatin, prevented oxaliplatin-induced mechanical hyperalgesia without affecting cold allodynia. Moreover, oxaliplatin caused phosphorylation of cofilin protein in the spinal cord, which has been shown to be involved in the neuropathic hyperalgesia. This increased phosphorylation of cofilin was also attenuated by gabapentin treatment. These results suggest that gabapentin is useful for relieving oxaliplatin-induced mechanical hyperalgesia and that the pathogenic mechanisms of cold allodynia and mechanical hyperalgesia differ.</description><identifier>ISSN: 1347-8613</identifier><identifier>EISSN: 1347-8648</identifier><identifier>DOI: 10.1254/jphs.14058FP</identifier><identifier>PMID: 24990115</identifier><language>eng</language><publisher>Japan: Elsevier B.V</publisher><subject><![CDATA[Actin Depolymerizing Factors - metabolism ; Amines - administration & dosage ; Amines - pharmacology ; Animals ; Antineoplastic Agents - administration & dosage ; Antineoplastic Agents - adverse effects ; cofilin ; Cold Temperature - adverse effects ; Cyclohexanecarboxylic Acids - administration & dosage ; Cyclohexanecarboxylic Acids - pharmacology ; Gabapentin ; gamma-Aminobutyric Acid - administration & dosage ; gamma-Aminobutyric Acid - pharmacology ; Hyperalgesia - chemically induced ; Hyperalgesia - metabolism ; Hyperalgesia - prevention & control ; Injections, Intraperitoneal ; Male ; mechanical allodynia ; Mice, Inbred Strains ; neuropathic pain ; Organoplatinum Compounds - administration & dosage ; Organoplatinum Compounds - adverse effects ; Oxaliplatin ; Phosphorylation - drug effects ; Spinal Cord - metabolism]]></subject><ispartof>Journal of Pharmacological Sciences, 2014/07/20, Vol.125(3), pp.292-299</ispartof><rights>2014 Copyright Elsevier B.V.</rights><rights>2014 The Japanese Pharmacological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963</citedby><cites>FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1347861319301239$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,4024,27923,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24990115$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohsawa, Masahiro</creatorcontrib><creatorcontrib>Otake, Saki</creatorcontrib><creatorcontrib>Murakami, Tomoyasu</creatorcontrib><creatorcontrib>Yamamoto, Shohei</creatorcontrib><creatorcontrib>Makino, Toshiaki</creatorcontrib><creatorcontrib>Ono, Hideki</creatorcontrib><creatorcontrib>Musashino University</creatorcontrib><creatorcontrib>Department of Pharmacognosy</creatorcontrib><creatorcontrib>Graduate School of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Nagoya City University</creatorcontrib><creatorcontrib>Laboratory of Clinical Pharmacy and Pharmacology</creatorcontrib><creatorcontrib>Faculty of Pharmacy</creatorcontrib><creatorcontrib>Laboratory of CNS Pharmacology</creatorcontrib><title>Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice</title><title>Journal of Pharmacological Sciences</title><addtitle>J Pharmacol Sci</addtitle><description>Oxaliplatin, a platinum-based chemotherapy drug, frequently causes acute and chronic peripheral neuropathies including mechanical hyperalgesia. These adverse effects hinder anticancer therapy with the drug. In this study, we examined several drugs that might prevent oxaliplatin-induced peripheral neuropathy. Single intraperitoneal (i.p.) injection of oxaliplatin (10 mg/kg) induced cold allodynia (acetone test) and mechanical hyperalgesia (von Frey test). Gabapentin, but not simvastatin and atorvastatin, prevented oxaliplatin-induced mechanical hyperalgesia without affecting cold allodynia. Moreover, oxaliplatin caused phosphorylation of cofilin protein in the spinal cord, which has been shown to be involved in the neuropathic hyperalgesia. This increased phosphorylation of cofilin was also attenuated by gabapentin treatment. These results suggest that gabapentin is useful for relieving oxaliplatin-induced mechanical hyperalgesia and that the pathogenic mechanisms of cold allodynia and mechanical hyperalgesia differ.</description><subject>Actin Depolymerizing Factors - metabolism</subject><subject>Amines - administration &amp; dosage</subject><subject>Amines - pharmacology</subject><subject>Animals</subject><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>cofilin</subject><subject>Cold Temperature - adverse effects</subject><subject>Cyclohexanecarboxylic Acids - administration &amp; dosage</subject><subject>Cyclohexanecarboxylic Acids - pharmacology</subject><subject>Gabapentin</subject><subject>gamma-Aminobutyric Acid - administration &amp; dosage</subject><subject>gamma-Aminobutyric Acid - pharmacology</subject><subject>Hyperalgesia - chemically induced</subject><subject>Hyperalgesia - metabolism</subject><subject>Hyperalgesia - prevention &amp; control</subject><subject>Injections, Intraperitoneal</subject><subject>Male</subject><subject>mechanical allodynia</subject><subject>Mice, Inbred Strains</subject><subject>neuropathic pain</subject><subject>Organoplatinum Compounds - administration &amp; dosage</subject><subject>Organoplatinum Compounds - adverse effects</subject><subject>Oxaliplatin</subject><subject>Phosphorylation - drug effects</subject><subject>Spinal Cord - metabolism</subject><issn>1347-8613</issn><issn>1347-8648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqFUk1v1DAQjRCIlsKNM8qRA1vGH7GdIyp0u1Kr9gBna-JMtl5lk2BnK_rvcTbbnJC4jK2Z5zcz7znLPjK4ZLyQX3fDY7xkEgpz_fAqO2dC6pVR0rxe7kycZe9i3AFwA0y9zc64LEtgrDjP1muscKBu9F3-EOgp3WJ-_wdbP7SYkqtNVx8c1fkduUfsvMM2v3keKGC7pegxT-_uvKP32ZsG20gfTudF9uv6x8-rm9Xt_Xpz9e125bSW46risii0Jq4dGoBKGdSShCQOZcNko1UtXMWJqqrijUZkjQSjGlUjCiyVuMg2M2_d484Owe8xPNsevT0m-rC1GEbvWrJYOa0M14WonYSKl0wBkFHIsZYlNInr88w1hP73geJo9z46alvsqD9Ey5SZCBQv_g8tpDYCBGcJ-mWGutDHGKhZpmRgJ8fs5Jg9OZbgn07Mh2pP9QJ-sSgB1jMgVSf5-671HdldfwhdUtq6RkXnqbMcmLSQOoCwANoCL_kUSp5Wh2LS7vvMtIsjbmlp9SLYPBcvrDjG04RLOfkfLHWJRs00lHx-8hTssX_6JD6QG5MR_t-r_gUQ_dIA</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Ohsawa, Masahiro</creator><creator>Otake, Saki</creator><creator>Murakami, Tomoyasu</creator><creator>Yamamoto, Shohei</creator><creator>Makino, Toshiaki</creator><creator>Ono, Hideki</creator><general>Elsevier B.V</general><general>The Japanese Pharmacological Society</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>DOA</scope></search><sort><creationdate>2014</creationdate><title>Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice</title><author>Ohsawa, Masahiro ; Otake, Saki ; Murakami, Tomoyasu ; Yamamoto, Shohei ; Makino, Toshiaki ; Ono, Hideki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Actin Depolymerizing Factors - metabolism</topic><topic>Amines - administration &amp; dosage</topic><topic>Amines - pharmacology</topic><topic>Animals</topic><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>cofilin</topic><topic>Cold Temperature - adverse effects</topic><topic>Cyclohexanecarboxylic Acids - administration &amp; dosage</topic><topic>Cyclohexanecarboxylic Acids - pharmacology</topic><topic>Gabapentin</topic><topic>gamma-Aminobutyric Acid - administration &amp; dosage</topic><topic>gamma-Aminobutyric Acid - pharmacology</topic><topic>Hyperalgesia - chemically induced</topic><topic>Hyperalgesia - metabolism</topic><topic>Hyperalgesia - prevention &amp; control</topic><topic>Injections, Intraperitoneal</topic><topic>Male</topic><topic>mechanical allodynia</topic><topic>Mice, Inbred Strains</topic><topic>neuropathic pain</topic><topic>Organoplatinum Compounds - administration &amp; dosage</topic><topic>Organoplatinum Compounds - adverse effects</topic><topic>Oxaliplatin</topic><topic>Phosphorylation - drug effects</topic><topic>Spinal Cord - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohsawa, Masahiro</creatorcontrib><creatorcontrib>Otake, Saki</creatorcontrib><creatorcontrib>Murakami, Tomoyasu</creatorcontrib><creatorcontrib>Yamamoto, Shohei</creatorcontrib><creatorcontrib>Makino, Toshiaki</creatorcontrib><creatorcontrib>Ono, Hideki</creatorcontrib><creatorcontrib>Musashino University</creatorcontrib><creatorcontrib>Department of Pharmacognosy</creatorcontrib><creatorcontrib>Graduate School of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Nagoya City University</creatorcontrib><creatorcontrib>Laboratory of Clinical Pharmacy and Pharmacology</creatorcontrib><creatorcontrib>Faculty of Pharmacy</creatorcontrib><creatorcontrib>Laboratory of CNS Pharmacology</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of Pharmacological Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohsawa, Masahiro</au><au>Otake, Saki</au><au>Murakami, Tomoyasu</au><au>Yamamoto, Shohei</au><au>Makino, Toshiaki</au><au>Ono, Hideki</au><aucorp>Musashino University</aucorp><aucorp>Department of Pharmacognosy</aucorp><aucorp>Graduate School of Pharmaceutical Sciences</aucorp><aucorp>Nagoya City University</aucorp><aucorp>Laboratory of Clinical Pharmacy and Pharmacology</aucorp><aucorp>Faculty of Pharmacy</aucorp><aucorp>Laboratory of CNS Pharmacology</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice</atitle><jtitle>Journal of Pharmacological Sciences</jtitle><addtitle>J Pharmacol Sci</addtitle><date>2014</date><risdate>2014</risdate><volume>125</volume><issue>3</issue><spage>292</spage><epage>299</epage><pages>292-299</pages><issn>1347-8613</issn><eissn>1347-8648</eissn><abstract>Oxaliplatin, a platinum-based chemotherapy drug, frequently causes acute and chronic peripheral neuropathies including mechanical hyperalgesia. These adverse effects hinder anticancer therapy with the drug. In this study, we examined several drugs that might prevent oxaliplatin-induced peripheral neuropathy. Single intraperitoneal (i.p.) injection of oxaliplatin (10 mg/kg) induced cold allodynia (acetone test) and mechanical hyperalgesia (von Frey test). Gabapentin, but not simvastatin and atorvastatin, prevented oxaliplatin-induced mechanical hyperalgesia without affecting cold allodynia. Moreover, oxaliplatin caused phosphorylation of cofilin protein in the spinal cord, which has been shown to be involved in the neuropathic hyperalgesia. This increased phosphorylation of cofilin was also attenuated by gabapentin treatment. These results suggest that gabapentin is useful for relieving oxaliplatin-induced mechanical hyperalgesia and that the pathogenic mechanisms of cold allodynia and mechanical hyperalgesia differ.</abstract><cop>Japan</cop><pub>Elsevier B.V</pub><pmid>24990115</pmid><doi>10.1254/jphs.14058FP</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1347-8613
ispartof Journal of Pharmacological Sciences, 2014/07/20, Vol.125(3), pp.292-299
issn 1347-8613
1347-8648
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_abc7682753dc40b291600e86a2ad490f
source ScienceDirect Journals
subjects Actin Depolymerizing Factors - metabolism
Amines - administration & dosage
Amines - pharmacology
Animals
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - adverse effects
cofilin
Cold Temperature - adverse effects
Cyclohexanecarboxylic Acids - administration & dosage
Cyclohexanecarboxylic Acids - pharmacology
Gabapentin
gamma-Aminobutyric Acid - administration & dosage
gamma-Aminobutyric Acid - pharmacology
Hyperalgesia - chemically induced
Hyperalgesia - metabolism
Hyperalgesia - prevention & control
Injections, Intraperitoneal
Male
mechanical allodynia
Mice, Inbred Strains
neuropathic pain
Organoplatinum Compounds - administration & dosage
Organoplatinum Compounds - adverse effects
Oxaliplatin
Phosphorylation - drug effects
Spinal Cord - metabolism
title Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T20%3A20%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gabapentin%20Prevents%20Oxaliplatin-Induced%20Mechanical%20Hyperalgesia%20in%20Mice&rft.jtitle=Journal%20of%20Pharmacological%20Sciences&rft.au=Ohsawa,%20Masahiro&rft.aucorp=Musashino%20University&rft.date=2014&rft.volume=125&rft.issue=3&rft.spage=292&rft.epage=299&rft.pages=292-299&rft.issn=1347-8613&rft.eissn=1347-8648&rft_id=info:doi/10.1254/jphs.14058FP&rft_dat=%3Cproquest_doaj_%3E1547830321%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1547830321&rft_id=info:pmid/24990115&rfr_iscdi=true